Northeast Pharmaceutical Achieves Milestone: Fosfomycin Trometamol API Earns CEP Certification from European Directorate for the Quality of Medicines & Healthcare - 7x24

7 x 24 Track global technological trends

Hot Topic

Day

News Topic

Northeast Pharmaceutical Achieves Milestone: Fosfomycin Trometamol API Earns CEP Certification from European Directorate for the Quality of Medicines & Healthcare

2025-06-04 / Read about 0 minute

Author：小编

Northeast Pharmaceutical has secured the Certificate of Suitability (CEP) for its fosfomycin trometamol Active Pharmaceutical Ingredient (API) from the European Directorate for the Quality of Medicines & Healthcare. This achievement positions Northeast Pharmaceutical as the first domestic enterprise to obtain this prestigious certification, signifying that its product meets the rigorous standards for high-end registration in the European Union and is now eligible for sale in relevant markets.

Previous page：U.S. ADP Employment in May Fell Short of Expectati...

Next page：Chinese Concept Stocks See Broad Gains in US Pre-m...

Return to List

Hot Reading

2 day ago

Cohere hires long-time Meta research head Joelle Pineau as its chief AI officer

1 day ago

An Apple Robot could be in your home soon – and it's powered by Siri

1 day ago

Is GPT-5 really worse than GPT-4o? Ars puts them to the test.

2 day ago

Upcoming DeepSeek AI model failed to train using Huawei’s chips